Search Results
Results found for "Luke Pattison"
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Drugs like Ozempic will change the world GPCR Events, Meetings, and Webinars November 5 - 7, 2024 | 16th receptor as a novel desensitization mechanism for G protein-coupled receptors, illustrated by dopamine D2-like
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
The conformation-selective antibody, Fab30, promotes partially activated βarr into the activated-like
- Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi...
We also showed that the EMC promotes surface expression of C3aR, likely explaining its identification
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
However, Gpr3-deficient mice display several adverse phenotypes, including elevated anxiety-like behavior
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
Mechanistically, GASP1 inhibited proteasomal degradation of insulin-like growth factor 1 receptor (IGF1R
- Targeting Intracellular Allosteric Sites in GPCRs
The significance of spatio-temporal attributes in signaling is demonstrated in processes like neurotransmission advances in structural biology have allowed researchers to visualize the binding of allosteric agonists like
- Canonical chemokine receptors as scavenging “decoys”
scavenging (D'Amico G. et al. 2000), becoming incapable of promoting cell migration, a phenomenon which is likely
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
dissociation from the receptor, the interaction of the extended finger loop with the lipid bilayer likely contributes to stabilizing β-arrestin in a membrane-bound, active-like conformation.
- Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin...
MDA-MB-231 cells are metastatic when implanted in mice while BT-20 are not and remain epithelial-like
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
the GPR37-mTOR-S6K1 Signaling GPCRs in Neuroscience Astrocyte Gi-GPCR signaling corrects compulsive-like
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
Like many other organs, various GPCRs play a role in regulating liver function.
- Do You Believe AI Could Accelerate Drug Discovery?
Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
Although such pheromone/receptor systems are likely to function in both mate choice and prezygotic isolation
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
This highlights the power of advanced imaging techniques like cryo-EM in solving complex biological puzzles
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
Gs-coupled receptors enriched in SKM has only a limited impact on whole-body glucose homeostasis, most likely
- How Schild Analysis Protects Your Conclusions in GPCR Research
Diagnose hidden effects like mixed receptor systems or slope deviations before they distort your interpretation
- How GPCR Collaboration Built an Innovation Engine
Most labs operated like small, competing startups.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
That’s why we partner with innovators like Revvity , whose new reagent family— pHSense™ —isn’t just another
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Hearing Terry speak is more than an academic experience — it’s like being handed a new set of tools to
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
CCR2 was also shown to be resistant to degradation and most likely recycling through the trans-Golgi D’Amico et. al 2000), becoming incapable of promoting cell migration, a phenomenon which is likely to
- Overview of adhesion GPCRs self-activation
Structurally they characterize by a long extracellular region of adhesion-like domains which modulate possible to know that ADGRL3 can activate and form stable complexes with Gs, Gi, Gq, and G12, where like
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Given the sensitive allosteric nature of GPCRs with their binding partners, tags or modifications are likely able to detect interaction with the strongest coupling partner Gαs (Figure 2A), and for the glucagon-like-peptide Manchanda and colleagues [37] showed that for the glucagon-like-peptide-1 receptor (GLP-1R), mini-Gs inhibited β-arrestin recruitment, receptor internalisation, and endosomal trafficking for the glucagon-like-peptide
- 📰 GPCR Weekly News, October 9 to 15, 2023
low relatedness Industry News Nobel Laureates Highlight Symposium Celebrating Lefkowitz’s 50 Years at Duke
- 📰 GPCR Weekly News, June 12 to 18, 2023
But before we delve into the latest news, we'd like to highlight some upcoming events and resources:
- 📰 GPCR Weekly News, May 15 to 21, 2023
If you are interested in giving a talk, contact us at Hello@DrGPCR.com, and if you would like to present
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
the evolutionary conservation of these residues can lead to the development of drugs that are less likely
- 📰 GPCR Weekly News, October 23 to 29, 2023
cell mobilization when combined with propranolol Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like
- Interacting binding insights and conformational consequences of the differential activity of...
contrast, when the GPR55 receptor is simulated in complex with the selective agonist ML186, agonist-like
- The Truth About GPCR Product Launches: Years in the Making
GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
that slow down or prevent good science from reaching patients — particularly in underfunded fields like












